N@N

RWR, THLD, DRAD, OPNT, PYB, MEDW Are Seasonally Ripe To Go Up In the Next Five Weeks

^{Published on 2012-08-16 04:00:26 - WOPRAI}
 

August 16, 2012 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Dj Wilshire Reit Etf (NYSE:RWR), Threshold Pharmaceuticals Inc (NASDAQ:THLD), Digirad Corp (NASDAQ:DRAD), OPNET Technologies Inc (NASDAQ:OPNT), PPlus Trust Series GSG-2 (NYSE:PYB), Mediware Information Systems Inc (NASDAQ:MEDW) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  RWR     Dj Wilshire Reit Etf             2.63%            90.00% (9 of 10)     Friday, August 31st 2012
  THLD    Threshold Pharmaceuticals Inc    10.16%           100.00% (7 of 7)     Tuesday, August 28th 2012
  DRAD    Digirad Corp                     3.53%            87.50% (7 of 8)      Tuesday, August 21st 2012
  OPNT    OPNET Technologies Inc           10.10%           75.00% (9 of 12)     Thursday, August 30th 2012
  PYB     PPlus Trust Series GSG-2         2.77%            100.00% (8 of 8)     Monday, September 3rd 2012
  MEDW    Mediware Information Systems Inc  5.62%            91.67% (11 of 12)    Wednesday, August 29th 2012

Threshold Pharmaceuticals Inc (NASDAQ:THLD) - Threshold Pharmaceuticals, Inc., a biotechnology company, engages in the discovery and development of drugs targeting the microenvironment of solid tumors for patients living with cancer. Its product line includes TH-302, a product candidate in Phase I and Phase I/II for the potential treatment of patients with cancer; and 2DG, a product candidate for the potential treatment of patients with cancer and has been evaluated in a Phase I clinical trial alone and in combination with docetaxel as a combination therapy. The company was founded in 2001 and is headquartered in Redwood City, California.

Digirad Corp (NASDAQ:DRAD) - Digirad Corporation provides diagnostic imaging products, and personnel and equipment leasing services primarily in the United States. The company operates in two segments, Digirad Imaging Solutions and Product. The Digirad Imaging Solutions segment offers various personnel and equipment leasing services for physicians to perform nuclear imaging, echocardiography, vascular ultrasound, or any combination of these procedures in their offices by leasing the imaging system, certified personnel, and other support required to perform imaging. This segment primarily serves cardiologists and internists. The Product segment manufactures and sells solid-state gamma cameras and accessories for general nuclear imaging and specific clinical-application imaging, as well as offers camera maintenance services. This segment sells its imaging systems to physician offices, hospitals, and imaging centers. The company was founded in 1985 and is headquartered in Poway, California.

OPNET Technologies Inc (NASDAQ:OPNT) - OPNET Technologies, Inc. provides software products and related services for managing applications and networks in the United States and internationally. Its software products include ACE Analyst, which troubleshoots performance problems in production applications; ACE Live that determines the root source of application performance problems; IT Guru Network Planner for predictive network capacity planning, design optimization, and validation of network configuration changes; and IT Guru Systems Planner that offers capacity planning for servers. The companys software products also comprise nCompass for enterprises that provides centralized, real-time visibility of network topology, traffic, and status in a single, integrated view; IT Sentinel for automatic and continuous network configuration integrity and security auditing, and proactive change validation; OPNET Panorama that offers system analytics for application performance management; and VNE Server that automatically maintains near real-time data model of the production IT network. In addition, its software products consist of SP Guru Network Planner that contains analytics that are valuable to service providers for planning, network design optimization, and validation of configuration changes; SP Guru Transport Planner, an optical network-planning product; nCompass for service providers; OPNET Modeler, a network modeling and simulation product; Modeler Wireless suite that incorporates additional functionality to wireless network research and development organizations; and Modeler Wireless suite for defense. The company also develops and sells various OPNET software modules to simulate and analyze networking technologies and communication protocols; and offers consulting services, software license updates, technical support and services, and training services. OPNET Technologies Inc. was founded in 1986 and is headquartered in Bethesda, Maryland.

PPlus Trust Series GSG-2 (NYSE:PYB) - Merrill Lynch Depositor Inc. PPLUS 5.75% Trust Certificates Series GSG

Mediware Information Systems Inc (NASDAQ:MEDW) - Mediware Information Systems, Inc. and its subsidiaries develop, market, license, implement, and support clinical management and performance management information software systems and solutions in the United States and the United Kingdom. It licenses and sells blood and biologics management products and solutions, including HCLL software (HCLL Transfusion and HCLL Donor) that addresses blood donor recruitment, blood processing, and transfusion activities for hospitals and medical centers; blood center technologies, which provides software tools and services to blood centers; and biologics products comprising BiologiCare, a bone, tissue, and cellular product tracking software that tracks and manages transplantable materials in hospitals, surgery centers, and other healthcare facilities. The company also supplies medication management solutions to hospitals, mental health facilities, specialty pharmacies, home infusion facilities, penal institutions, and other institutions that require the administration and management of medication. Its medication management products include WORx, a core pharmacy information system designed to manage inpatient and outpatient pharmacy operations; MediCOE, a physician order entry module that enables clinicians to enter medication orders and manage drug therapy; and MediMAR, a nurse point of care administration and bedside documentation module, which serves as an electronic medication administration and bedside documentation record. In addition, Mediware Information Systems provides the Insight software system, a business and clinical intelligence software package that tracks performance metrics to assist healthcare managers to manage their organizations, as well as collects data from the information systems across a hospital to create understandable graphical dashboards. The company was founded in 1970 and is headquartered in Lenexa, Kansas.

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641